Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: a framework for personalized risk assessment and counseling.

Journal of cancer education : the official journal of the American Association for Cancer Education - 1 Jan 2007

Matloff Ellen T, Shannon Kristen M, Moyer Anne, Col Nananda F

Abstract excerpt

BACKGROUND: Menopausal women with a family history of breast cancer have several treatment options, including tamoxifen, raloxifene, and hormone therapy. This complex decision should be based on each woman's risk to develop breast cancer, menopausal symptoms, preferences, and risks for other conditions. Current models in use do not include pedigree analysis, personalized risk assessment, or genetic testing in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Estrogen Antagonists

Share to Health Knowledge, Attitudes, Practice

Share to Health Status

Share to Menopause

Share to Tamoxifen

Source

Identifiers

PMID: 17570802
DOI: 10.1007/BF03174368

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: a framework for personalized risk assessment and counseling.PMID 17570802Read ↗

Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Semantic proximity Read ↗

Identification and management of women with a family history of breast cancer: Practical guide for clinicians.Semantic proximity Read ↗

Personalized assessment and management of women at risk for breast cancer in North America.Semantic proximity Read ↗

Clinical assessment of breast cancer risk based on family history.Semantic proximity Read ↗

Application of breast cancer risk prediction models in clinical practice.Semantic proximity Read ↗

Genetic counseling for breast cancer risk: how did we get here and where are we going?Semantic proximity Read ↗

Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral.Semantic proximity Read ↗

A practical approach to breast cancer risk assessment and management of women at elevated risk.Semantic proximity Read ↗

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women.Semantic proximity Read ↗

Comprehensive Care of Women With Genetic Predisposition to Breast and Ovarian Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.